29 results
8-K
EX-99.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
products, and the company culture. Cintia was instrumental in designing and steering our commercial model design and her leadership will be critical
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
and probity and support the chairman, directors and senior management in instilling the appropriate culture, values and behaviours in the boardroom
8-K
EX-10.4
ADAP
Adaptimmune Therapeutics Plc
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
high standards of integrity and probity and support the chairman, directors and senior management in instilling the appropriate culture, values
8-K
EX-10.2
o5pd tk9j
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
424B3
ef16pfewhs7 5el
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
99je6 fsd
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
c3y4u6151f6tbzs4kq
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.4
ipoxb652 3bm62a
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
stnatq5lj
6 May 19
Adaptimmune TRANSFORMING T CELL THERAPY Clinical and Business Update
8:11am